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Objective: Following chronic liver injury or when hepatocyte proliferation is impaired, ductular 
reactions (DR) containing hepatic progenitor cells (HPC) appear in the periportal regions and 
can regenerate the liver parenchyma. HPCs exist in a niche composed of myofibroblasts, 
macrophages and laminin matrix. Galectin-3 (Gal-3) is a β-galactoside-binding lectin that binds 
to laminin and is expressed in injured liver in mice and humans. 
Design: We examined the role of Gal-3 in HPC activation. HPC activation was studied following 
dietary induced hepatocellular (choline-deficient ethionine-supplemented diet) and billiary (3,5-
diethoxycarbonyl-1,4-dihydrocollidine supplemented diet) injury in wild type and Gal-3(-/-) mice. 
Results: HPC proliferation was significantly reduced in Gal-3(-/-) mice. Gal-3(-/-) mice failed to 
form a HPC niche, with reduced laminin formation. HPCs isolated from wild type mice secrete 
Gal-3 which enhanced adhesion and proliferation of HPCs on laminin in an undifferentiated 
form.  These effects were attenuated in Gal3(-/-) HPCs and in wild type HPCs treated with the 
Gal-3 inhibitor lactose. Gal-3(-/-) HPCs in vitro showed increased hepatocyte function and 
prematurely upregulated both biliary and hepatocyte differentiation markers and regulated cell 
cycle genes leading to arrest in G0/G1. 
Conclusions: We conclude that Gal-3 is required for the undifferentiated expansion of HPCs in 






What is already known about this subject?  
How might it impact on clinical practice in the foreseeable future 
• Chronic liver disease accounts for 1.3% of all deaths worldwide.  
• Following prolonged or severe liver injury ductular reactions (DRs) occur which contain 
hepatic progenitor cells (HPCs) which can differentiate into hepatocytes and biliary 
epithelium and can regenerate the liver parenchyma.   
• Understanding the mechanisms that control DR expansion and HPC differentiation is 
crucial for the development of novel therapies to promote "healthy" liver regeneration. 
 
What are the new findings?  
• Our work has described the role of the beta-galactoside binding lectin galectin-3 (Gal-3) 
in the HPC niche. 
• We show that Gal-3 facilitates DR expansion and promotes HPC interaction with laminin 
matrix and controls HPC differentiation.  
• Mice deficient in Gal-3 display reduced HPC activation following biliary and 
hepatocellular injury. 
• Gal-3 promotes the expansion of HPCs in an undifferentiated form. 
 
How might it impact on clinical practice in the foreseeable future 
• Gal-3 has an important role in the response to injury in the liver and inhibitors of Gal-3 
function are being developed for liver fibrosis.   
• A better understanding of its role in liver regeneration may lead to novel therapies for 
chronic liver disease. 
  
Introduction 
Liver cirrhosis accounts for 1.3% of all deaths worldwide and is a common precursor to the 
development of liver cancer which is the 3rd commonest cause of cancer death in men and 6th in 
women (WHO Global Burden of Disease Report 2004). In response to injury, the healthy liver 
restores its parenchymal mass through the division of mature liver cells- hepatocytes and bile 
duct cells. However following prolonged or severe liver injury hepatocyte mediated regeneration 
is impaired [1, 2] and ductular reactions (DRs) develop in the liver. DRs are thought to contain a 
population of hepatic progenitor cells (HPCs) which can differentiate under clonogenic 
conditions in vitro into hepatocytes and biliary epithelial cells [3]. DRs have been described in 
many forms of chronic human liver disease [4, 5, 6] and in severe acute liver disease [7].  
Furthermore, a correlation exists between the extent of liver disease and the magnitude of the 
accompanying DRs [8]. Understanding the mechanisms controlling HPC activation is therefore 
important and may enable the development of therapeutic strategies to improve regeneration in 
chronic liver injury.  
 
HPCs are surrounded by a “niche” composed of myofibroblasts, macrophages and the 
basement membrane which includes laminin [9].  We have shown that the cellular components 
of the HPC niche have an important effect upon the fate of HPCs [10] and both cell-cell and 
matrix-cell interactions within the niche are believed to influence HPC behaviour [9, 11, 12, 13].  
Galectin 3 (Gal-3) is a 30kDa glycoprotein belonging to the β-galactoside-binding lectin family 
that is upregulated in injured liver [11, 14] and regulates myofibroblast activation and fibrosis 
[14]. Gal-3 has been reported to bind integrins and regulates β1 mediated adhesion to ECM [15, 
16, 17] an interaction that can promote integrin signaling, adhesion, remodeling and fibronectin 
fibrillogenesis [18]. However no studies have examined the role of Gal-3 in DR/HPC activation. 
We have modelled two forms of liver injury; biliary injury and regeneration with the 3,5-
diethoxycarbonyl-1,4-dihydrocollidine (DDC) diet, and hepatocellular injury with the choline 
deficient ethionine supplemented (CDE) diet [10]. Here we report that Gal-3 is highly expressed 
within the HPC niche, is actively secreted by HPCs and macrophages, is important for the 





Animal work was carried out under procedural guidelines of the Home Office (UK). Mice with 
global and constitutive deletion of Gal-3 on a C57/Bl6J background [19] and strain matched 
C57/Bl6J WT mice from Harlan (UK) were used in this study. Eight-week old male mice were 
given 12 days of a choline deficient diet (MPbio, UK) supplemented with 0.15% DL-ethionine 
(Sigma-Aldrich, UK) in the drinking water [20]. Billiary activation was induced by administration 
of 0.1% 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) in the diet for 14 days. Animals 
undergoing partial hepatectomy were anesthetized with isofluorane. After a midline laparotomy, 
the left and middle lobes (~70%) of the liver were ligated at the base and removed. The 
abdominal wall and skin were sutured separately. BrdU was injected (50 mg/kg I.P.) 2 h prior to 
harvesting at 48h post hepatectomy.  
 
Human Liver 
Retrospectively collected specimens of human liver were obtained from the South East 
Scotland SAHSC BioResource 
 
Immunohistochemistry 
Formalin-fixed paraffin embedded sections were stained with picrosirius red and were 
processed for immunohistochemistry using the following antibodies: rabbit anti-PanCK (DAKO), 
rat anti F4/80 (eBioscience), rat anti-Gal-3 (Cedarlane), rabbit anti-BrDU (Abcam), rabbit anti-
YM1 (Stem Cell Techologies) and the appropriate biotinylated secondary antibodies (DAKO) or 
alexa fluor conjugated antibodies (Invitrogen).   
 
Cell counting and morphometric analysis of laminin deposition 
For counting of DRs, 40 high power (x20) fields with liver parenchyma at all boundaries were 
counted. Ductular cells were recognized by the small (approximately 10m) oval/cuboidal 
morphology with high nuclear to cytoplasmic ratio. Cells with hepatocyte like morphology (larger 
(> 20m) with low nuclear to cytoplasmic ratio were not counted.  For the quantification of 
proliferating ductular cells. Ki67 and PanCK double positive cells were counted from 10 high 
power (x20) fields. Laminin was scored from 40 high power (x20) fields. Livers from mice with 
partial hepatectomy were stained for BrdU and positive hepatocytes were counted from 20 (x20) 
fields. 
 HPCs purification and culture 
Following DR/HPC induction with CDE diet, livers were harvested, minced, then incubated with 
L15 medium (Sigma) containing 50ug/ml DNase 1 (Roche), and 250g/ml Collagenase type V 
(Sigma) at 37oC in a shaking incubator for 45 min. Liver cells were then strained through a 
40m filter, centrifuged three times at 50 x g for 1 min to remove hepatocytes. The non-
parenchymal cells were resuspended in HPC Complete Medium: 45% DMEM High Glucose 
(PAA), 45% Ham’s F10 Medium (PAA,) 10% FBS (Hyclone), 1g/ml Insulin, 50 g/ml 
hydrocortisone (Sigma), 50 g/ml gentamycin, 2.5 ml sodium pyruvate (PAA). HPCs were then 
purified by centrifugation through a discontinuous gradient of 20 and 50% Percoll™ (Sigma) in 
PBS at 1400 × g for 20 min. The lower layer was collected separately and washed twice with 
PBS. Leucocytes were depleted with anti-mouse CD45R/B220 magnetic particles (Beckton 
Dickenson). The negative fraction was resuspended in HPC Medium with 10% serum. To 
reduce fibroblast contamination, cells were plated for 8–12 h to remove adherent cells. Cells 
were replated and cultured in a humidified atmosphere with 5% CO2 at 37 °C. LPC Medium with 
5% serum and was replaced after 2 days.  A more stringent protocol was also employed to 
isolate HPCs where HPCs were isolated by triple sorting for CD24, CD133 and EpCAM. Non-
parenchymal cells were resuspended in PBS + 2% FCS and incubated with EpCAM-APC 
(eBiosciences); CD24-PeCy7, CD133-FITC, CD45-PE, CD31-PE and Ter119-PE (all from 
Biolegend). Hematopoeitic cells (CD45+), erythroid cells (Ter119), and endothelial cells 
(CD31+) were excluded by gating. 7-Aminoactinomycin D (7-AAD) was used to label dead cells 
for exclusion. Cells were analysed and sorted with FACS Aria II (Beckton Dickenson).  Isolated 
cells formed colonies in collagen gels and single clones were isolated and expanded in vitro. 
 
Primary HPCs proliferation and differentiation in vitro 
WT and Gal-3(-/-) HPCs were cultured on laminin-coated or uncoated tissue culture plates, cells 
were fixed with methanol and stained for pan-CK. For HPC differentiation, cells were suspended 
in 2% matrigel in growth medium supplemented with 50 ng/ml epithelial growth factor (EGF, 




Primary non-parenchymal cells were incubated with mouse lineage cocktail (anti-Ter-119-PE, 
anti-CD45-PE, anti-CD31-PE), anti-CD34 PeCy7, anti-EpCam-APC (all from Biolegend) and 
viability dye eFluor 780 (EBiosciences) anti-mouse Gal-3-FITC (Mac-2, Cedarlane) or Gal-3-
FITC plus anti-F480-APC and analysed using a LSR Fortessa II flow cytometer (Beckton 
Dickenson) and Flowjo software.  Stellate cells were identified by autofluorescence [21]. 
 
Western Blotting 
Cell extracts were resolved by SDS-PAGE and immunoblots  probed overnight at 4°C with 
primary antibody, (rabbit anti--actin (Sigma Aldrich), rabbit anti-phospho-FAK, rabbit anti-
Phospho-AKT, mouse anti-cyclin D1 (all from Cell Signaling), mouse anti-galectin-3 clone 
A3A12 (Alexis Biochemicals, UK) and appropriate horseradish peroxidase-lableled secondary 
antibodies (DAKO). Signal was detected using ECL reagent (GE Healthcare).  
 
BMOL culture 
BMOLs were kindly provided by Prof. George Yeoh and Dr Janina E E Tirnitz Parker. BMOLs 
were cultured in RPMI media with 5% FBS (PAA), 2mM L-glutamine (PAA), 10U/ml penicillin; 
100ug/ml streptomycin (PAA), 30ng/ml IGF2 (Invitrogen), 20ng/ml EGF (Sigma) and 10ug/ml 
insulin (Sigma). Cells were cultured in a humidified atmosphere with 95% O2 / 5% CO2 at 37°C. 
 
BMDM isolation and co-culture 
BMDMs were isolated as previously described (Mackinnon et al., 2008) from WT or Gal-3(-/-) 
mice and cultured in DMEM/F12 media containing 20% L929 conditioned media and 10% FBS. 
For co-culture experiments BMOL cells and BMDMs were washed and incubated overnight prior 
to seeding together at a 1:1 ratio in BMOL growth media.  Cells were cultured for 72h prior to 




SiRNA-mediated knockdown of mouse Gal-3 expression was carried out using duplexes against 
the target sequence CACAATCATGGGCACAGTGAA. Transfection with Hiperfect (Qiagen) was 
performed according to the manufacturer’s protocol.  
 
Immunofluorescence 
HPCs were immunostained using routine methods, primary antibodies rabbit anti-pan-
cytokeratin (DAKO), rabbit anti-sox-9 (Abcam), rat anti-Ki67 (Leica), mouse anti-alpha-SMA 
(Sigma) and rat anti-Gal-3 (Cedarlane) were used in 1% BSA in PBS for 1hr.  Secondary 
antibodies were donkey anti-rabbit 488, goat anti-rabbit 568 or donkey anti-rat 488 (1:250 in 1% 
BSA in PBS).  
 
Quantitative real-time RT-PCR analysis.  
RNA was prepared using RNeasy (Qiagen), as per the manufacturer’s protocol. 100ng RNA 
was used for cDNA synthesis using Superscript II First Strand Synthesis System (Invitrogen), 
with random hexamer primers. Quantitative real-time PCR was performed for cDNA samples 
using SYBR Green master mix (Qiagen) and Quantitect primers (Qiagen) as follows; Gamma-
glutamyl transpeptidase (GT, Cat. No. QT00104209), aquaporin-1 (Cat. No. QT00109242), 
hepatocyte nuclear factor 4 (HNF-4, Cat. No. QT00144739), albumin (Cat. No. QT00115570), 
cytokeratin-19 (Cat. No. QT00156667).  
 
PCR array 
cDNA from control duplex and galectin-3 siRNA transfected BMOL cells was applied to a mouse 
cell cycle RT2 Profiler PCR Array (SABiosciences PAMM-020Z) as per manufacturer’s 
instructions.  Data analysis was carried out using an integrated web-based software package 
(SA Biosciences) based on the 2-ΔΔCT method with normalization of the raw data to GapDH and 
is expressed as fold regulation compared to cells transfected with scrambled duplex. 
 
MTT Cell Proliferation Assay 
Cells were plated (7.5 ×103 cells / well) in replicates of 6 in 96-well culture plates and treated 
with 50 mM lactose or 50 mM sucrose for 2 or 4 days. To measure the cell proliferation, 20μl of 
5 mg/ml MTT (Sigma) was added into each well and assayed using standard methodology. 
 
Cell Adhesion Assay 
Cell adhesion was assayed using BMOL cells on plastic culture plates coated with either laminin 
or 10% poly-L-lysine for positive control at 37˚C for 2 hour.  After incubation, the cells were fixed 
and stained with Diff-Quick. The plate was washed with water then 50μl DMSO was added into 
wells. The plate was then read in a plate reader at 660 nm wavelength.  
 
ELISA Assay 
Mouse serum albumin and Gal-3 were measured by ELISA (albumin; Alpha Diagnostics, Gal-3 
Duoset kit, R&D Systems) according to the manufacturer’s instructions.  
 
Cell Cycle analysis 
Cell cycle stage was measured by DNA content analysis by flow cytometry following labeling of 
methanol fixed cells with propidium iodide.  Doublets were excluded by analysis of FL2-area 
against FL2-width using a FacsCaliber (Beckton Dickenson) and Flowjo software. 
 
Measurement of P450 enzyme activity 
Functional analysis of cytochrome p450 activity (CYP1A2) was performed using p450-Glo 
systems according to the manufacturer’s protocol (Promega).  
Results 
 
Hepatic Gal-3 expression is upregulated and associated with the CDE-diet induced DRs. 
Bile ducts from WT mice were identified by pan-cytokeratin (pan-CK, Figure 1A).  Gal-3 was 
localised mainly to macrophages and some bile duct epithelia in control diet mice. WT mice fed 
a CDE diet showed typical peri-ductular reaction with pan-CK positive ductular cells migrating 
into the parenchyma away from periportal area. Mice fed the CDE diet for 12 days showed 
significantly higher liver Gal-3 mRNA levels than control-diet fed mice (Figure 1B) and 
numerous Gal-3 positive cells were observed in the peri-portal region of CDE-fed mouse livers. 
Dual immunofluorescence staining showed a spatial association between the DRs and Gal-3 
(Figure 1C). Gal-3 was strongly expressed in macrophages within the niche and also in some 
pan-CK positive progenitor cells and hepatocytes surrounding the niche (Figure 1C, 
supplemental Figure S1A). A strong association between DRs and Gal-3 was also observed in 
human cirrhotic liver of diverse aetiologies including diseases affecting the biliary system 
(primary sclerosing cholangitis, PSC and primary biliary cirrhosis, PBC) and hepatocellular 
injury (Hepatitis C virus infection, HCV) where Gal-3 was expressed on and around pan-CK 
positive DRs (Figure 1D).  
 
Gal-3 is critical for ductular expansion and proliferation in vivo and associated niche 
formation 
WT and Gal-3(-/-) mice were given CDE diet for 12 days.  Gal-3(-/-) livers showed only few pan-
CK positive cells and these were almost exclusively bile ductular cells located in the periportal 
tracks (Figure 2A).  This was also confirmed when livers were stained with sox-9 (Figure 2A 
lower panels).  The number of ductular cells was significantly decreased in Gal-3(-/-) mice 
(Figure 2B p<0.05). Importantly, the absence of a ductular response in Gal-3(-/-) livers was not 
associated with protection from the hepatotoxic effects of the CDE diet on the mice. In contrast, 
serum transaminase activity was higher in Gal-3(-/-) mice compared to WT (Figure 2C). Further, 
other parameters of morbidity including weight loss, matting of the fur and withdrawal from 
socialisation were routinely monitored, and were not distinguishably different between strains. 
To address whether the reduced number of DRs in Gal-3(-/-) mice was associated with reduced 
proliferation of ductular cells, we conducted dual-staining for Ki67 and pan-CK to determine the 
in situ proliferative index of DRs in CDE treated livers (Figure 2D). Pan-CK/Ki67 dual positive 
cells were observed in WT but not Gal-3(-/-) CDE treated livers (Figure 2D) and the proliferative 
index was 7 fold higher in WT compared to Gal-3(-/-) mice confirming that the proliferation of 
these cells was affected by the absence of Gal-3 (Figure 2E p<0.05). The number of 
proliferating hepatocytes however was low and was not markedly different between genotypes 
(Supplemental Figure S2A).  We immunostained sections for typical HPC niche components 
and showed that unlike WT mice, Gal-3(-/-) mice failed to form a typical laminin sheath that 
surrounds HPCs radiating from the periportal area (Figure 2F). The amount of laminin in CDE-
fed Gal-3(-/-) mouse livers was significantly less than that in CDE-fed WT mouse livers (Figure 
2G, P<0.01).  The number of infiltrating macrophages was reduced in Gal-3(-/-) mice compared 
to WT (Figure 2F,G).  This was due to a reduced number of M2 activated macrophages as cells 
positive for the M2 marker YM-1 were reduced in the Gal-3(-/-) mice compared to WT 
(Supplemental Figure S2B).  Following biliary injury with DDC diet YM-1 positive cells were 
seen around the areas of the ductular reaction and on Kupffer cells within the parenchyma.  
Ductular YM-1 positive cells were not observed in the Gal-3(-/-) livers. Recruitment of 
neutrophils and CD3 positive T cells was not significantly altered following CDE diet and there 
was no reduction in Gal-3(-/-) mice. (Supplemental Figure S3). 
  
In WT mice, biliary injury induced by DDC diet resulted in ductular proliferation with periductal 
fibrosis (Figure 3).  Numerous pan-CK-positive and sox-9 positive ductular cells were seen 
around portal tracts (Figure 3A).  In contrast there were fewer ducts/portal tract and reduced 
fibrosis in Gal-3(-/-) mice compared to WT (Figure 3B,C).  Dual immunofluorescence staining 
revealed that Gal-3 was expressed on cells surrounding the proliferating ductular cells and on 
some ductular cells themselves (Figure 3D).  However significant co-staining for Gal-3 was 
observed on alpha-smooth muscle actin positive stellate cells and macrophages following DDC 
diet (Supplemental Figure S1A).  Moreover flow cytometric analysis showed that Gal-3 was 
expressed both on F480-positive macrophages and stellate cells from non-parenchymal cells 
isolated from DDC treated WT livers (Supplemental Figure S1B). 
 
Our results suggest a role for Gal-3 in progenitor mediated liver regeneration, therefore we 
sought to examine the role of Gal-3 in hepatocyte driven regeneration following partial 
hepatectomy.  Liver weights and the number of proliferating BrdU positive hepatocytes was not 
significantly different between WT and Gal-3(-/-) mice (Supplemental Figure S4). 
 
Gal-3 promotes HPC adhesion and proliferation on laminin  
We isolated HPCs from CDE-fed mouse livers.  FACS analysis showed that lineage negative, 
CD24 and EpCAM positive HPCs expressed Gal-3 (Figure 4A). On day 4 post isolation HPCs 
were > 95% positive for sox-9 and pan-CK (Figure 5B) and co-expressed Gal-3 diffusely within 
the cytoplasm (Figure 4B). Using a second method we isolated highly sorted HPCs (CD45-
/CD31-/Ter119-/CD24+/EpCAM+/CD133+) from the non-parenchymal fraction of livers of mice 
that had received the CDE diet (supplemental Figure S5A).  We have previously shown that 
these cells are clonogenic and have bipotential differentiation capacity yielding cells of a 
hepatocyte and biliary morphology in vitro at clonal density [22].  We confirmed that this highly 
sorted population could be differentiated down a biliary or hepatocellular lineage (Supplemental 
Figure S6B). Yields of CD24+CD133+EpCAM+ HPCs were 2.8% of the lineage negative 
fraction in WT livers and 1.7% in Gal-3(-/-) livers. Transfection of these cells with siRNA to Gal-3 
increased the spontaneous differentiation of these cells down a hepatocellular or biliary fate 
(supplemental Figure S5C).   
 
WT HPCs when plated on laminin rapidly adopted an epithelial morphology (Figure 4C) and up-
regulated expression and secretion of Gal-3 (Figure 4D). BMOL cells also adhered readily to 
laminin (Figure 4E). This adhesion was significantly inhibited by lactose, an extracellular Gal-3 
inhibitor, whereas no effect was seen with an equimolar concentration of sucrose (Figure 4E). 
Primary HPCs from WT mice plated on laminin showed significantly increased proliferation 
compared to those maintained on plastic (Figure 4F). Similar results were obtained with the 
BMOL cell line (Figure 4G).    
 
Absence/inhibition of Gal-3 inhibits proliferation of HPC on laminin 
To determine the effects of extracellular Gal-3 upon HPC proliferation we examined the effect of 
lactose and sucrose on primary HPC proliferation by MTT assay. Lactose inhibited growth of 
WT HPCs on laminin compared to sucrose control or untreated cells (Figure 5A). Gal-3(-/-) 
HPCs grew at a significantly slower rate than WT cells (Figure 5B). The effect of Gal-3 on cell 
growth suggested that Gal-3 may modulate cell cycle progression.  To address this we used 
BMOL cells transfected with siRNA to Gal-3.  siRNA transfection resulted in >90% knockdown 
of Gal-3 expression measured by qPCR, flow cytometry, ELISA and western blot (Figure 5C). 
Transfected cells were analysed for cell cycle progression by DNA content analysis by 
propidium iodide staining (Figure 5D).  At 72h post transfection inhibition of Gal-3 expression 
resulted in a significant reduction in the percentage of cells in G2 (from 25 to 13%) indicating a 
block in cell cycle progression at the G0/G1 phase of the cell cycle (Figure 5D). To further 
investigate effects on the cell cycle, a mouse cell cycle PCR array was performed on RNA 
isolated from transfected BMOLs plated on laminin.  Inhibition of Gal-3 expression in BMOL 
cells resulted in decreased expression of >1.5 fold of several key cell cycle regulatory genes 
including cyclinD1, CDK1, CDK6, cdc6, Chek1, and Rbl1 and decreased expression of mitotic 
assembly genes NEK2 and RAD21 coupled with an increased expression of checkpoint genes 
Ddit3 and CKS1b and the cell cycle inhibitory gene P16 (Figure 5E).  To explore this further we 
examined changes in the expression of cyclinD1 in primary HPCs and showed a reduction in 
expression in Gal-3(-/-) HPCs (Figure 5F).  We also show that Gal-3 deletion results in reduced 
activation of the downstream integrin signaling intermediates focal adhesion kinase (FAK) and 
Akt (Figure 5F).  These results are consistent with Gal-3 mediating adhesion of HPCs in the 
niche which facilitates integrin engagement and signaling leading to cell cycle progression. 
 
Gal-3 facilitates the expansion of HPCs in an undifferentiated phenotype 
We then sought to examine whether inhibition of Gal-3 expression induced differentiation of 
HPCs. To induce bi-lineage differentiation of HPCs, a combination of matrigel and EGF was 
employed [23]. Differentiation of HPCs plated on plastic rapidly invoked changes in their gene 
expression consistent with maturation into terminally differentiated epithelium. After 5 days in 
culture this resulted in upregulation of both hepatic and biliary markers in BMOLs plated on 
plastic, whereas culture on laminin (with matrigel and EGF) suppressed this effect 
(Supplemental Figure S6). This suggests that laminin enables the maintenance of HPCs in an 
undifferentiated form in vitro.  In contrast, both primary HPC isolates (Figure 6A-E) and BMOLs 
subjected to siRNA knockdown (Supplemental Figure S6F-K) differentiated readily on laminin.  
Interestingly, there was no apparent lineage-bias induced by the absence of Gal-3; both mature 
biliary and hepatocytic genes were upregulated in knockout/knock down cultures compared to 
control.  Furthermore, hepatocyte functional assays were performed by measuring albumin 
secretion and CYP1A2 activity. These data demonstrate that there is a significantly higher 
albumin secretion and CYP1A2 activity in Gal-3 siRNA transfected BMOLs than in control 
transfected cells. (Figure 6F,G) These data suggest that Gal-3, together with laminin, is 
important for maintaining the undifferentiated state of HPCs in the hepatic niche. 
 
Macrophages contribute to the Gal-3 composition of the HPC niche 
Macrophages are a major Gal-3 expressing cell component of the HPC niche in the 
regenerating liver.  Culture supernatants from bone marrow derived macrophages (BMDMs) 
plated for 24h contained five times as much Gal-3 as that produced by equal numbers of HPCs 
(Figure 7A). BMDMs from WT or Gal-3(-/-) mice were co-cultured with BMOL cells and 
proliferation measured by MTT assay. Co-culturing control BMOLs for 3 days with either WT or 
Gal-3(-/-) BMDMs had no effect on BMOL proliferation.  However when Gal-3 expression was 
inhibited in BMOLs there was reduced BMOL proliferation which could be at least partially 
rescued by co-culturing with WT macrophages (Figure 7B).   
Discussion 
 
Gal-3 is a beta galactoside binding lectin most often associated with inflammation and fibrotic 
injury in various tissues, including liver [14, 24, 25] and is elevated in chronic liver injury in mice 
and humans [11, 14] and has been associated with worsening fibrosis, with Gal-3(-/-) mice 
showing reduced scarring. In acute injury Gal-3(-/-) mice show reduced hepatitis following 
concanavilin-A [26] and acetaminophen [27, 28] induced injury.  Therefore in most of these 
studies the absence of Gal-3 has been associated with beneficial outcome and scar free repair. 
However none of these models result in a significant DR and impaired hepatocyte proliferation 
similar to that seen in many forms of chronic human liver disease.  
 
Here we show that Gal-3 is elevated in the CDE model of liver injury with DRs/HPC activation 
and hepatocyte regeneration.  We found numerous Gal-3 expressing cells localized to and 
around the DRs spreading from the periportal area of the liver. In mouse liver, we observed Gal-
3 positive cells within the niche but was primarily associated with macrophages rather than the 
HPCs themselves. Gal-3 also known as Mac-2 has been used as a macrophage marker in 
several tissues [29].  Expression of Gal-3 in niche macrophages suggests that Gal-3 may be 
involved in cross-talk between HPCs and their supporting environment, which is believed to be 
crucial in mediating the homeostatic balance between proliferation and differentiation of HPCs 
during liver regeneration [9, 10, 22, 30]. We also observed a population of Gal-3 positive 
hepatocytes in CDE-treated mice. We could speculate that's these cells are newly formed 
hepatocytes arising from differentiated progenitors but this would require further confirmation. 
Gal-3 positive hepatocytes were also observed in human liver (although clearly less strongly 
positive than the ducts), This may reflect differences in the chronicity of the diseases in humans 
and mice.    
We found that Gal-3(-/-) mice demonstrated reduced macrophage infiltration and lacked a DR 
response to the CDE diet, despite showing increased liver injury.  The reduced number of 
macrophages in Gal-3-/- livers may result in reduced clearance of ALT leading to elevated 
levels in the serum [31].  The number and the proportion of proliferating ductular cells was 
significantly reduced in Gal-3(-/-) mice indicating a direct effect of Gal-3 upon cell proliferation.  
Similarly, DRs were reduced in Gal-3(-/-) mice following biliary injury with the DDC diet.  In the 
DDC diet hepatic stellate cell-derived Gal-3 may contribute to the progenitor expansion. This 
confirms our previous work [10] which demonstrates that myofibroblasts associate with 
proliferating ducts during billiary injury but not hepatocellular injury (CDE). In contrast we show 
that deficiency of Gal-3 has no effect on hepatocyte mediated regeneration following partial 
hepatectomy. 
 
Laminin forms a dynamic sheath flanking proliferating DR/HPCs, and unlike other matrices 
permits HPC proliferation in an undifferentiated form [9, 32] and discussed in [33]). We show 
that laminin facilitates proliferation and suppresses differentiation of HPCs and that these 
effects are promoted by Gal-3.  Absence or knockdown of Gal-3 promoted differentiation into a 
more mature phenotype with expression of both biliary and hepatocyte markers.  We show that 
HPCs in culture secrete Gal-3 and that lactose inhibits Gal-3 mediated adhesion and 
proliferation on laminin. The mechanism whereby Gal-3 mediates its effect on HPC proliferation 
is not completely understood but it is known to directly bind and activate cyclin D1 in the 
nucleus [34, 35, 36, 37]. We showed that there was reduced expression of cyclin D1 by western 
blot in Gal-3(-/-) HPCs and found that growth of Gal-3 knockout/down HPCs on laminin was 
slower in vitro and  there was an accumulation of cells in G1/0 and a reduction in the % of cells 
in G2/M consistent with cell cycle arrest in G1/0. There was a reduction in expression of cell 
cycle regulatory molecules, cyclins and CDKs and reduced expression of proteins involved in 
mitosis and chromosome assembly (RAD21 and NEK2) and an increased expression of the cell 
cycle inhibitor P16 and checkpoint protein Ddit3.  
 
Most adherent cells require integrins to progress through the cell cycle either by controlling 
growth factor signaling or by activating enzymes that are necessary for the G1 phase of the cell 
cycle [38]. Gal-3 has been shown to directly bind 1-integrin and modulates adhesion to ECM 
components [39, 40, 41] and has been shown to stabilise FAK in focal adhesions and increase 
FAK and Akt phosphorylation [18, 42]. We show that integrin-mediated signaling was inhibited 
in Gal-3(-/-) HPCs compared to WT cells when plated on laminin. This could be due to binding 
of Gal-3 to its putative membrane receptor CD98 [43, 44] which can modulate integrin function 
by a direct interaction with 1-integrin tails [44, 45]. There are also several studies that 
implicate an intracellular signaling role for galectin-3 [36, 46, 47] and Gal-3 has been shown to 
directly modulate cyclins [36].  Our work showing that the effect of Gal-3 in the context of HPC 
proliferation and adhesion and the role of FAK all of which are inhibited by lactose suggest 
primarily an extracellular effect. 
 
We show that co-culture with Gal-3 expressing macrophages could restore proliferation of Gal-3 
depleted HPCs in vitro, suggesting that recruited cells contribute to the Gal-3 expression within 
the niche.  We propose that Gal-3 (secreted by HPCs and niche macrophages) stimulates 
DR/HPC expansion by supporting adhesion to the laminin sheath and activating integrin 
signaling leading to cell cycle progression (Supplemental Figure 8).  
 
How would a proliferative effect on HPCs impact on fibrosis?  On one hand matrix deposition 
(principally laminin) is necessary for HPC proliferation, whilst the ductular reaction promotes 
excessive matrix deposition leading to fibrosis.  We have shown that these processes can be 
manipulated in opposing directions by macrophages which could be explained by differing 
matrix responses at each pole of the ductular reaction (biliary vs hepatocytic) [10, 22, 48].  The 
differential regulation of these processes would impact on the eventual outcome. Our results 
coupled with the well described profibrotic role of Gal-3 would support a hypothesis that 
suggests that Gal-3 within the niche stimulates HPC expansion.  HPCs emerging from the niche 
would be exposed to a low Gal-3 environment that would favour differentiation but upon 
persistent injury leads to matrix deposition and fibrosis. 
  
Acknowledgements: SJF, ACM and W-CH are funded by grant allocations from the MRC (UK) 
and the Sir Jules Thorn Trust. 
 










1 Marshall A, Rushbrook S, Davies SE, Morris LS, Scott IS, Vowler SL, et al. Relation between hepatocyte 
G1 arrest, impaired hepatic regeneration, and fibrosis in chronic hepatitis C virus infection. Gastroenterology 
2005;128:33-42. 
2 Diehl AM, Chute J. Underlying potential: cellular and molecular determinants of adult liver repair. J Clin 
Invest 2013;123:1858-60. 
3 Dorrell C, Erker L, Schug J, Kopp JL, Canaday PS, Fox AJ, et al. Prospective isolation of a bipotential 
clonogenic liver progenitor cell in adult mice. Genes & development 2011;25:1193-203. 
4 Clouston AD, Powell EE, Walsh MJ, Richardson MM, Demetris AJ, Jonsson JR. Fibrosis correlates with a 
ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis. Hepatology 
2005;41:809-18. 
5 Richardson MM, Jonsson JR, Powell EE, Brunt EM, Neuschwander-Tetri BA, Bhathal PS, et al. 
Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. 
Gastroenterology 2007;133:80-90. 
6 Gouw AS, Clouston AD, Theise ND. Ductular reactions in human liver: diversity at the interface. 
Hepatology 2011;54:1853-63. 
7 Katoonizadeh A, Nevens F, Verslype C, Pirenne J, Roskams T. Liver regeneration in acute severe liver 
impairment: a clinicopathological correlation study. Liver international : official journal of the International 
Association for the Study of the Liver 2006;26:1225-33. 
8 Lowes KN, Brennan BA, Yeoh GC, Olynyk JK. Oval cell numbers in human chronic liver diseases are 
directly related to disease severity. Am J Pathol 1999;154:537-41. 
9 Lorenzini S, Bird TG, Boulter L, Bellamy C, Samuel K, Aucott R, et al. Characterisation of a stereotypical 
cellular and extracellular adult liver progenitor cell niche in rodents and diseased human liver. Gut 2010;59:645-54. 
10 Boulter L, Govaere O, Bird TG, Radulescu S, Ramachandran P, Pellicoro A, et al. Macrophage-derived 
Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nat Med 2012;18:572-9. 
11 Terada T, Nakanuma Y. Expression of tenascin, type IV collagen and laminin during human intrahepatic 
bile duct development and in intrahepatic cholangiocarcinoma. Histopathology 1994;25:143-50. 
12 Paku S, Schnur J, Nagy P, Thorgeirsson SS. Origin and structural evolution of the early proliferating oval 
cells in rat liver. Am J Pathol 2001;158:1313-23. 
13 Lorenzini S, Bird TG, Boulter L, Bellamy C, Samuel K, Aucott R, et al. Characterisation of a stereotypical 
cellular and extracellular adult liver progenitor cell niche in rodents and diseased human liver. Gut;59:645-54. 
14 Henderson NC, Mackinnon AC, Farnworth SL, Poirier F, Russo FP, Iredale JP, et al. Galectin-3 regulates 
myofibroblast activation and hepatic fibrosis. Proc Natl Acad Sci U S A 2006;103:5060-5. 
15 Saravanan C, Cao Z, Head SR, Panjwani N. Detection of differentially expressed wound-healing-related 
glycogenes in galectin-3-deficient mice. Investigative ophthalmology & visual science 2009;50:5690-6. 
16 Friedrichs J, Torkko JM, Helenius J, Teravainen TP, Fullekrug J, Muller DJ, et al. Contributions of galectin-
3 and -9 to epithelial cell adhesion analyzed by single cell force spectroscopy. J Biol Chem 2007;282:29375-83. 
17 Friedrichs J, Manninen A, Muller DJ, Helenius J. Galectin-3 regulates integrin alpha2beta1-mediated 
adhesion to collagen-I and -IV. J Biol Chem 2008;283:32264-72. 
18 Lagana A, Goetz JG, Cheung P, Raz A, Dennis JW, Nabi IR. Galectin binding to Mgat5-modified N-glycans 
regulates fibronectin matrix remodeling in tumor cells. Molecular and cellular biology 2006;26:3181-93. 
19 Hsu DK, Yang RY, Pan Z, Yu L, Salomon DR, Fung-Leung WP, et al. Targeted disruption of the galectin-3 
gene results in attenuated peritoneal inflammatory responses. Am J Pathol 2000;156:1073-83. 
20 Knight B, Akhurst B, Matthews VB, Ruddell RG, Ramm GA, Abraham LJ, et al. Attenuated liver progenitor 
(oval) cell and fibrogenic responses to the choline deficient, ethionine supplemented diet in the BALB/c inbred 
strain of mice. Journal of hepatology 2007;46:134-41. 
21 Ichikawa S, Mucida D, Tyznik AJ, Kronenberg M, Cheroutre H. Hepatic stellate cells function as regulatory 
bystanders. J Immunol 2011;186:5549-55. 
22 Bird TG, Lu WY, Boulter L, Gordon-Keylock S, Ridgway RA, Williams MJ, et al. Bone marrow injection 
stimulates hepatic ductular reactions in the absence of injury via macrophage-mediated TWEAK signaling. Proc 
Natl Acad Sci U S A 2013;110:6542-7. 
23 Li WL, Su J, Yao YC, Tao XR, Yan YB, Yu HY, et al. Isolation and characterization of bipotent liver 
progenitor cells from adult mouse. Stem Cells 2006;24:322-32. 
24 MacKinnon AC, Farnworth SL, Hodkinson PS, Henderson NC, Atkinson KM, Leffler H, et al. Regulation of 
alternative macrophage activation by galectin-3. J Immunol 2008;180:2650-8. 
25 Henderson NC, Mackinnon AC, Farnworth SL, Kipari T, Haslett C, Iredale JP, et al. Galectin-3 Expression 
and Secretion Links Macrophages to the Promotion of Renal Fibrosis. Am J Pathol 2008;172:288-98. 
26 Volarevic V, Milovanovic M, Ljujic B, Pejnovic N, Arsenijevic N, Nilsson U, et al. Galectin-3 deficiency 
prevents concanavalin A-induced hepatitis in mice. Hepatology 2012;55:1954-64. 
27 Dragomir AC, Sun R, Choi H, Laskin JD, Laskin DL. Role of galectin-3 in classical and alternative 
macrophage activation in the liver following acetaminophen intoxication. J Immunol 2012;189:5934-41. 
28 Dragomir AC, Sun R, Mishin V, Hall LB, Laskin JD, Laskin DL. Role of galectin-3 in acetaminophen-
induced hepatotoxicity and inflammatory mediator production. Toxicological sciences : an official journal of the 
Society of Toxicology 2012;127:609-19. 
29 Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 
2011;11:723-37. 
30 Bird TG, Lorenzini S, Forbes SJ. Activation of stem cells in hepatic diseases. Cell and tissue research 
2008;331:283-300. 
31 Radi ZA, Koza-Taylor PH, Bell RR, Obert LA, Runnels HA, Beebe JS, et al. Increased serum enzyme 
levels associated with kupffer cell reduction with no signs of hepatic or skeletal muscle injury. Am J Pathol 
2011;179:240-7. 
32 Clayton E, Forbes SJ. The isolation and in vitro expansion of hepatic Sca-1 progenitor cells. Biochem 
Biophys Res Commun 2009;381:549-53. 
33 Williams MJ, Clouston AD, Forbes SJ. Links between hepatic fibrosis, ductular reaction and progenitor cell 
expansion. Gastroenterology 2013. 
34 Cheong TC, Shin JY, Chun KH. Silencing of galectin-3 changes the gene expression and augments the 
sensitivity of gastric cancer cells to chemotherapeutic agents. Cancer Sci;101:94-102. 
35 Kim HR, Lin HM, Biliran H, Raz A. Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast 
epithelial cells. Cancer Res 1999;59:4148-54. 
36 Lin HM, Pestell RG, Raz A, Kim HR. Galectin-3 enhances cyclin D(1) promoter activity through SP1 and a 
cAMP-responsive element in human breast epithelial cells. Oncogene 2002;21:8001-10. 
37 Cheong TC, Shin JY, Chun KH. Silencing of galectin-3 changes the gene expression and augments the 
sensitivity of gastric cancer cells to chemotherapeutic agents. Cancer Sci 2010;101:94-102. 
38 Wang X, Foster M, Al-Dhalimy M, Lagasse E, Finegold M, Grompe M. The origin and liver repopulating 
capacity of murine oval cells. Proc Natl Acad Sci U S A 2003;100 Suppl 1:11881-8. 
39 Ochieng J, Warfield P, Green-Jarvis B, Fentie I. Galectin-3 regulates the adhesive interaction between 
breast carcinoma cells and elastin. J Cell Biochem 1999;75:505-14. 
40 Ochieng J, Leite-Browning ML, Warfield P. Regulation of cellular adhesion to extracellular matrix proteins 
by galectin-3. Biochem Biophys Res Commun 1998;246:788-91. 
41 Ochieng J, Green B, Evans S, James O, Warfield P. Modulation of the biological functions of galectin-3 by 
matrix metalloproteinases. Biochim Biophys Acta 1998;1379:97-106. 
42 Goetz JG, Joshi B, Lajoie P, Strugnell SS, Scudamore T, Kojic LD, et al. Concerted regulation of focal 
adhesion dynamics by galectin-3 and tyrosine-phosphorylated caveolin-1. J Cell Biol 2008;180:1261-75. 
43 Dong S, Hughes RC. Macrophage surface glycoproteins binding to galectin-3 (Mac-2-antigen). Glycoconj J 
1997;14:267-74. 
44 Henderson NC, Collis EA, Mackinnon AC, Simpson KJ, Haslett C, Zent R, et al. CD98hc (SLC3A2) 
interaction with beta 1 integrins is required for transformation. J Biol Chem 2004;279:54731-41. 
45 Fenczik CA, Sethi T, Ramos JW, Hughes PE, Ginsberg MH. Complementation of dominant suppression 
implicates CD98 in integrin activation. Nature 1997;390:81-5. 
46 Hsu DK, Chen HY, Liu FT. Galectin-3 regulates T-cell functions. Immunological reviews 2009;230:114-27. 
47 Haudek KC, Spronk KJ, Voss PG, Patterson RJ, Wang JL, Arnoys EJ. Dynamics of galectin-3 in the 
nucleus and cytoplasm. Biochim Biophys Acta 2010;1800:181-9. 
48 Thomas JA, Pope C, Wojtacha D, Robson AJ, Gordon-Walker TT, Hartland S, et al. Macrophage therapy 
for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function. Hepatology 
2011;53:2003-15. 
49 Vestentoft PS, Jelnes P, Hopkinson BM, Vainer B, Mollgard K, Quistorff B, et al. Three-dimensional 






Figure 1 – Gal-3 expression is up-regulated during DR expansion in vivo. (A). 
Representative sections of liver from control and CDE fed mice immunostained for ductular cells 
(pan-CK) and Gal-3 (scale bar = 50m). (B) Whole liver gene expression of Gal-3 was 
significantly elevated in 12-day CDE diet fed mice versus controls (n=6, P<0.05). (C) Dual 
staining for pan-CK (red) and Gal-3 (green) following 12 days CDE diet showing Gal-3 positive 
cells in periportal zones of the ductular reaction.  Arrows designate dual positive cells (scale bar 
= 10 m). (D) Representative immunostaining for Gal-3 and pan-CK in sections from normal 
human liver and liver section from patients with primary biliary cirrhosis (PBC), hepatitis virus C 
(HCV) and primary sclerosing cholangitis (PSC). Arrows indicate Gal-3 expression within DRs 
(scale bar = 50 m). 
 
Figure 2 – Gal-3 knockout mice have reduced DR proliferation in response to a CDE diet. 
(A) Pan-CK and sox-9 staining in livers from WT and Gal-3(-/-) mice fed CDE diet for 12 days 
(scale bar = 50 m). (B) Quantification of pan-CK staining showed consistently fewer HPCs in 
the livers of Gal-3(-/-) mice fed CDE diet than those in the equivalent WT (n=6, **P<0.01). (C) 
Serum alanine transaminase (ALT) activity was higher in Gal-3(-/-) mice compared to WT at the 
end of the experiment. (D) Ki67 staining yielded significantly fewer positive nuclei, suggestive of 
reduced HPC proliferation in Gal-3(-/-) mice (scale bar = 25 m).  (E) This was confirmed by 
dual-staining and counts of pan-CK (green) and Ki67 (red).  Arrows indicate double-positive 
cells. Both overall ductular cell number and the proliferative index of ductular cells were 
significantly lower in Gal-3(-/-) compared to WT (Student’s T-test, n=6; ** P<0.01). (F) 
Immunostaining for laminin was performed on serial sections of liver from wild type (WT) and 
Gal-3(-/-) mice fed CDE diet for 12 days. Representative immunostaining of the same area in 
each liver is illustrated (scale bar = 25 m). Gal-3(-/-) mice failed to form all elements of the 
HPC nice following CDE diet induction. (G) Laminin and macrophage scoring analysis showed a 
significant lower expression of laminin and reduced macrophage accumulation in CDE-fed Gal-
3(-/-) mice liver compared to WT controls (** P<0.01, n=6).   
 
 
Figure 3 – Gal-3(-/-) mice show reduced DR in response to DDC diet.  Wild type (WT) and 
Gal-3(-/-) mice received DDC supplemented diet for 14 days.  (A) Sections of WT and Gal-3(-/-) 
livers stained for pan-CK, sox-9 and sirius red (scale bar = 50m).  Digital image analysis 
quantification of pan-CK (B) and collagen (sirius red) staining (C) showing fewer pan-CK 
positive ductular cells were around portal tracts in Gal-3(-/-) mice compared to WT with reduced 
fibrosis (* P<0.05, n=5). (D) Co-immunofluorescence staining for Gal-3 (green) and pan-CK (red) 
in WT (left) and Gal-3(-/-) mice (right).  Arrows show dual positive cells. 
 
 
Figure 4 – Gal-3 promotes HPC adhesion to laminin.  (A) Cells from collagenase digested 
WT CDE-fed mouse livers were analysed by flow cytometry.  Lineage-EpCAM+CD24+ cells 
(histogram) were positive for Gal-3.  (B) Leucocyte and endothelial depleted cells were cultured 
for 4 days and immunostained for pan-CK (red) and Gal-3 (green) left panel, and sox-9 (red) 
and Gal-3 (green) right panel (scale bar = 25m).  Nuclei were stained with DAPI.  (C) Phase 
contrast images of HPCs adhered to plastic or laminin coated plates showing spreading and 
epithelial morphology on laminin.  Original magnification: x 200. (D) Gal-3 expression measured 
by ELISA was increased in HPCs plated on laminin for 24h. (E) Pre-treatment of BMOL cells 
with 50 mM lactose (lac) but not 50 mM sucrose (suc) significantly reduced adhesion to laminin 
(LM, *** P<0.001, n=5).  Primary (F) or BMOL (G) HPCs were cultured on laminin or plastic and 
their proliferation assayed by MTT assay (**P<0.01, n=5). 
 
Figure 5 – Absence of Gal-3 inhibits proliferation of HPCs on laminin. (A) MTT assay 
showing inhibition of primary WT HPC growth on laminin with 50 mM lactose but not sucrose 
(n=4, ** P<0.01).  (B) Cell counts of primary HPCs from Gal-3(-/-) and WT mice plated for 4 
days on laminin (n=4, *P<0.05, compared to WT). (C) BMOLcells were transfected with siRNA 
to Gal-3 or control duplex and after 72h Gal-3 knockdown was assessed by ELISA (n=4), qPCR 
(n=4), flow cytometry and western blot (representative of 4 independent experiments). (D) 
Control and Gal-3 siRNA treated HPCs were fixed and DNA content assessed by propidium 
iodide staining and flow cytometry after gating out doublets.  Gal-3 siRNA treated cells showed 
decreased % of cells in G2/M and increased % of cells in G1 (representative trace from 4 
experiments). (E) Transcripts from control transfected and Gal-3 siRNA transfected HPCs 72h 
post transfection was analysed using a mouse cell cycle RT-profiler PCR Array.  Results are 
expressed as fold regulation compared to control.  The results are the mean + SEM of 4 arrays. 
(F) Primary HPCs from WT and Gal-3(-/-) mice were cultured on laminin for  4 days and lysates 
probed for cyclin D1 and phosphorylated FAK and Akt, Gal-3 and -actin. Absence of Gal-3 
conferred reduced cyclin-D protein levels and reduced phosphorylation of FAK and Akt. 
 
Figure 6 – Gal-3 is required for the maintenance of an undifferentiated phenotype on 
laminin.  Primary HPCs were isolated and cultured on laminin under differentiating conditions 
(matrigel and EGF as described in Methods).  Expression of hepatic (albumin) and biliary 
markers ( GT, CK19 and aquaporin-1 [49]) was determined by qPCR and expressed as % 
relative to untreated control cells. After 5 days of differentiation, Gal-3(-/-) HPCs exhibited 
increased expression of both the biliary cell markers: CK19 (A), GGT (B),  Aquaporin-1 (C) and 
the hepatocyte marker: albumin (D), indicating that HPCs require Gal-3 to maintain an 
undifferentiated phenotype on laminin.  Further hepatocyte functional analysis showed 
significantly higher albumin secretion (E) and CYP1A2 activity (F) in Gal-3 siRNA transfected 
BMOLs. (n=3, *P<0.05;**P,0.01;***P<0.001). 
 
Figure 7 – Macrophage derived Gal-3 stimulates HPC proliferation in vitro and in vivo.  (A) 
Gal-3 was measured by ELISA in 24h culture supernatants from BMDMs and WT HPCs. (B) 
Control and Gal-3 siRNA transfected HPCs co-cultured with WT or Gal-3(-/-) BMDMs was 
measured by MTT assay. Inhibition of Gal-3 expression in BMOLs resulted in reduced 
proliferation which was partially restored when cells were cultured with WT but not Gal-3(-/-) 
BMDMs (n=3,  *P<0.05).  
 
 
 
 
 
